Anvesh Reddy Kompelli
Role not yet determined Is this you? Add your title
Also affiliated: Louisiana State University (2016); Medical University of South Carolina (2018–2022); University of Arkansas Medical Center (2026); Willis-Knighton Cancer Center (2019); Louisiana State University Health Sciences Center New Orleans (2022); Louisiana State University Health Sciences Center Shreveport (2016–2019)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Anvesh Reddy Kompelli's research focuses on the clinical outcomes of various medical treatments, with a particular emphasis on head and neck cancers. His work includes investigating the impact of treatment delays on patient survival rates, as demonstrated in studies on laryngeal cancers and head and neck cancers generally. Kompelli also explores specific treatment modalities, such as the inhibition of mTOR signaling with rapamycin for head and neck cancer and cryotherapy for chronic rhinitis. His research methodology often involves systematic reviews and meta-analyses, as seen in his work on hypoglossal nerve stimulation for obstructive sleep apnea.
Kompelli has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Gresham T. Richter, James Reed Gardner, and Kyle P. Davis, with whom he has co-authored multiple publications. His scholarship metrics include an h-index of 11, with 32 total publications and 706 citations.
Metrics
- h-index: 11
- Publications: 33
- Citations: 707
Selected Publications
-
Systematic Review and Meta‐Analysis of the Management and Outcomes of Recurrent Ranulas (2026)
-
Is Outpatient Supraglottoplasty Possible? Examination of Perioperative Comorbidities and Outcomes (2024)
-
Deoxycholic Acid for Submental Convexity: A MAUDE Database Analysis (2024)
-
Infantile Hemangioma Treated with Propranolol Readmission Trends, Complications of Therapy, and Cost: A PHIS Database Study (2022)
-
Postoperative and 1‐Year Functional Outcomes After Free Flap Surgery Among Patients 80 Years or Older (2022)
-
Cutaneous hyperpigmentation following bleomycin sclerotherapy for vascular malformations (2021)
-
Hereditary Hemorrhagic Telangiectasia and Aspirin‐Exacerbated Respiratory Disease: A Case Report (2021)
Collaboration Network
Top Collaborators
- Cutaneous hyperpigmentation following bleomycin sclerotherapy for vascular malformations
- Infantile Hemangioma Treated with Propranolol Readmission Trends, Complications of Therapy, and Cost: A PHIS Database Study
- Is Outpatient Supraglottoplasty Possible? Examination of Perioperative Comorbidities and Outcomes
- Systematic Review and Meta‐Analysis of the Management and Outcomes of Recurrent Ranulas
- Postoperative and 1‐Year Functional Outcomes After Free Flap Surgery Among Patients 80 Years or Older
- Infantile Hemangioma Treated with Propranolol Readmission Trends, Complications of Therapy, and Cost: A PHIS Database Study
- Hereditary Hemorrhagic Telangiectasia and Aspirin‐Exacerbated Respiratory Disease: A Case Report
- Cutaneous hyperpigmentation following bleomycin sclerotherapy for vascular malformations
- Postoperative and 1‐Year Functional Outcomes After Free Flap Surgery Among Patients 80 Years or Older
- Infantile Hemangioma Treated with Propranolol Readmission Trends, Complications of Therapy, and Cost: A PHIS Database Study
- Infantile Hemangioma Treated with Propranolol Readmission Trends, Complications of Therapy, and Cost: A PHIS Database Study
- Is Outpatient Supraglottoplasty Possible? Examination of Perioperative Comorbidities and Outcomes
- Hereditary Hemorrhagic Telangiectasia and Aspirin‐Exacerbated Respiratory Disease: A Case Report
- Hereditary Hemorrhagic Telangiectasia and Aspirin‐Exacerbated Respiratory Disease: A Case Report
- Cutaneous hyperpigmentation following bleomycin sclerotherapy for vascular malformations
- Postoperative and 1‐Year Functional Outcomes After Free Flap Surgery Among Patients 80 Years or Older
- Postoperative and 1‐Year Functional Outcomes After Free Flap Surgery Among Patients 80 Years or Older
- Postoperative and 1‐Year Functional Outcomes After Free Flap Surgery Among Patients 80 Years or Older
- Postoperative and 1‐Year Functional Outcomes After Free Flap Surgery Among Patients 80 Years or Older
- Postoperative and 1‐Year Functional Outcomes After Free Flap Surgery Among Patients 80 Years or Older
- Postoperative and 1‐Year Functional Outcomes After Free Flap Surgery Among Patients 80 Years or Older
- Infantile Hemangioma Treated with Propranolol Readmission Trends, Complications of Therapy, and Cost: A PHIS Database Study
- Infantile Hemangioma Treated with Propranolol Readmission Trends, Complications of Therapy, and Cost: A PHIS Database Study
Similar Researchers
Based on overlapping research topics